Global Health Ltd announces Q2FY2026 results

Global Health Limited (NSE: Medanta, BSE: 543654), one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India, today announced its audited consolidated financial results for the quarter ending 30th September, 2025.

Consolidated Highlights of the Quarter Ended 30th September, 2025 (Q2 FY2026)

- Consolidated Total Income of INR 11,189 million, compared to INR 9,748 million in Q2 FY25; reflecting a growth of 14.8 % y-o-y

- EBITDA1 (ex-Noida3) grew 13.7 % y-o-y to INR 2,804 with margins of 25.2% compared to 25.3% in Q2 FY25. Including Noida, EBITDA was INR 2,607 million, up 5.7% y-o-y, with margins at 23.3%

- Medanta Noida commenced operations in September 2025. The hospital generated Revenue of INR 39 million and EBITDA loss of INR 197 million

- Profit After Tax was INR 1,584 million, growth of 21.1% y-o-y. PAT margins improved to 14.2% from 13.4% in Q2 FY25

- During the quarter, 37 new beds were added at Patna, taking total bed addition to 57 beds in H1 FY26 in Patna

- Occupied bed days increased by 7.7% y-o-y, representing an occupancy of ~64% on increased bed capacity

- ARPOB grew by 5.5% y-o-y to INR 65,570 in Q2 FY26, driven by increase in realization and change in speciality mix

- Volume growth remained robust, In-patient count increased by 12.7% and Out-patient count increased by 14.9% y-o-y

- Matured hospitals revenue was INR 7,200 million, growth of 5.4% y-o-y. EBITDA was INR 1,696 million, growth of 0.4% y-o-y

- Developing hospitals ex Noida, Revenue was INR 3,531 million, growth of 28.3% y-o-y. EBITDA increased 34.0% YoY to INR 1,112 million, with margins improving to 31.5% compared to 30.1% in Q2 FY25. Including Noida, EBITDA stood at INR 915 million, with margin of 25.6%, reflecting the impact of initial ramp-up costs

- International Patients Revenue increased by 48.5% y-o-y to INR 762 million in Q2 FY26, driven by increased international patient volume

- OPD Pharmacy (Hospital & Retail) continues to register strong double digit growth. Revenue increased by 23.9% y-o-y to INR 456 million in Q2 FY26

Commenting on Q2 FY2026 results, Mr. Pankaj Sahni, Group CEO and Director said: "We are extremely pleased to share that in September 2025, we launched our sixth hospital, a stateof-the-art, 550-bed facility in Noida. Over 150 doctors across key specialties have already joined the hospital, supported by the deployment of advanced medical technologies, they will be able to deliver world-class care in the region. We are encouraged by the initial response from the community and are progressively ramping up operations.

During the quarter, the Company delivered a strong performance, with Revenue Growth of 15% year-on-year and 6% sequential growth. EBITDA (excluding Noida) grew 14% year-on-year and 10% sequentially. Growth momentum remained broad-based across our network.

Shares of Global Health Limited was last trading in BSE at Rs. 1251.45 as compared to the previous close of Rs. 1280.20. The total number of shares traded during the day was 393731 in over 738 trades.

The stock hit an intraday high of Rs. 1279.65 and intraday low of 1247.00. The net turnover during the day was Rs. 492968744.00.

Source : Equity Bulls

Keywords

GlobalHealth Hospital Medanta INE474Q01031 Q2FY26 H1FY26 ResultUpdate